StonvexLoading…
StonvexStonvexStonvexCore line items from IRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.20M | $10.99M | $19.05M | $39.85M |
Operating Income | $-38.60M | $-62.07M | $-10.56M | $18.23M |
Net Income | $-49.59M | $-57.53M | $-9.99M | $17.89M |
EPS (Diluted) | $-0.80 | $-2.15 | $-0.46 | $0.87 |
Total Assets | $50.24M | $36.86M | $53.95M | $48.99M |
Total Liabilities | $34.90M | $11.29M | $4.04M | $2.75M |
Cash & Equivalents | $45.09M | $30.32M | $50.50M | $42.63M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 69.89M | 31.57M | 23.98M | 20.86M |